HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alfredo Cagnotto Selected Research

Apolipoproteins E (ApoE)

10/2014Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: implications for therapy of Alzheimer disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alfredo Cagnotto Research Topics

Disease

11Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2011
4Catalepsy
11/2014 - 01/2002
3Dementia (Dementias)
05/2016 - 08/2012
3Gliosis
11/2009 - 10/2006
2Ischemia
05/2005 - 09/2003
2Brain Ischemia (Cerebral Ischemia)
05/2005 - 09/2003
1Colonic Neoplasms (Colon Cancer)
04/2022
1Cachexia
04/2022
1Atrophy
04/2022
1Hepatocellular Carcinoma (Hepatoma)
04/2022
1Neoplasms (Cancer)
04/2022
1Disease Progression
01/2021
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2019
1Brain Neoplasms (Brain Tumor)
12/2015
1Schizophrenia (Dementia Praecox)
11/2014
1Neurodegenerative Diseases (Neurodegenerative Disease)
08/2012
1Status Epilepticus (Complex Partial Status Epilepticus)
08/2011
1Seizures (Absence Seizure)
12/2010
1Decapitation
12/2010
1Mitochondrial Diseases (Mitochondrial Disease)
11/2009
1Obesity
01/2009
1Nervous System Diseases (Neurological Disorders)
03/2008
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
03/2008
1Pulmonary Hypertension
09/2005
1Atherosclerosis
09/2005
1Hypertension (High Blood Pressure)
09/2005
1Infarction (Infarctions)
05/2005
1Cognitive Dysfunction
01/2004
1Inflammation (Inflammations)
09/2003

Drug/Important Bio-Agent (IBA)

10Peptides (Polypeptides)IBA
04/2022 - 01/2011
9Proteins (Proteins, Gene)FDA Link
04/2022 - 11/2009
9Amyloid (Amyloid Fibrils)IBA
01/2021 - 12/2011
3Antipsychotic Agents (Antipsychotics)IBA
11/2014 - 01/2002
2Pharmaceutical PreparationsIBA
12/2015 - 03/2008
2Liposomes (Liposome)IBA
10/2014 - 10/2014
2Phosphatidic Acids (Phosphatidic Acid)IBA
10/2014 - 12/2011
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
08/2011 - 10/2006
2Glutamine (L-Glutamine)FDA Link
12/2010 - 11/2009
2Glutamic Acid (Glutamate)FDA Link
12/2010 - 11/2009
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2008 - 09/2003
1Dexamethasone (Maxidex)FDA LinkGeneric
04/2022
1Messenger RNA (mRNA)IBA
04/2022
1Amino AcidsFDA Link
04/2022
1ApelinIBA
04/2022
1PrionsIBA
01/2022
1Pyrrolidonecarboxylic Acid (Pyroglutamic Acid)IBA
01/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2015
1Apolipoproteins E (ApoE)IBA
10/2014
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
08/2012
1Biological ProductsIBA
08/2012
1Cardiolipins (Cardiolipin)IBA
12/2011
1Kainic Acid (Kainate)IBA
12/2010
1Glucose (Dextrose)FDA LinkGeneric
12/2010
1gamma-Aminobutyric Acid (GABA)IBA
12/2010
1Acetates (Acetic Acid Esters)FDA Link
12/2010
1Neuroprotective AgentsIBA
11/2009
1Serotonin (5 Hydroxytryptamine)IBA
01/2009
1Serotonin AgentsIBA
01/2009
1Dopamine (Intropin)FDA LinkGeneric
01/2009
1Type I Tumor Necrosis Factor ReceptorsIBA
03/2008
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
10/2006
1Endothelins (Endothelin)IBA
09/2005
1reparixinIBA
05/2005
1Peroxidase (Myeloperoxidase)IBA
05/2005
1ProlactinIBA
01/2004
1Phencyclidine (Angel Dust)IBA
01/2004
1ErythropoietinFDA Link
09/2003
1CytokinesIBA
09/2003
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
09/2003
1Interleukin-6 (Interleukin 6)IBA
09/2003

Therapy/Procedure

1Therapeutics
10/2014